Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 40,000 shares at $79.77 ($3.2M) on 2025-12-01, disclosed to the SEC on 2025-12-03.
Scheduled sale ($3.2M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |
| CORT | SELL | 2025-10-03 | $6.8M | — | Filing → |